Results 221 to 230 of about 715,847 (243)

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Nature, 2018
Yulei Wang, Sanjeev Mariathasan, Alessandra Castiglioni   +2 more
exaly  

Paracervical-Blockade

1972
openaire   +1 more source

Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy

Journal of Internal Medicine, 2018
Tasuku Honjo
exaly  

Tumour-intrinsic resistance to immune checkpoint blockade

Nature Reviews Immunology, 2020
Anusha Kalbasi, Antoni Ribas
exaly  

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?

Frontiers in Immunology, 2017
Ken H Young, Zijun Y Xu-monette
exaly  

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

Nature, 2016
Sadna Budhu, Arnab Ghosh, Jedd D Wolchok
exaly  

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Cell, 2017
Spencer C Wei, I De Bruyn, Alexandria P Cogdill   +2 more
exaly  

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells

Immunity, 2019
Asaf Madi, Giulia Escobar, Max Klapholz
exaly  

Fetal neuromuscular blockade

American Journal of Obstetrics and Gynecology, 1988
C.Neil Herrick, M. Mark Taslimi
openaire   +3 more sources

A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy

Nature, 2017
Nadeem Riaz, Vladimir Makarov, Vinod P Balachandran   +2 more
exaly